<DOC>
	<DOCNO>NCT01307995</DOCNO>
	<brief_summary>The aim study evaluate reduce incretin effect observe patient T2DM relation reversibility . The incretin effect measure mean OGTT iIVGTT 12 woman GDM pregnancy ( third trimester ) , 2-3 month post partum . It anticipate incretin effect patient GDM reduce - like patient form DM . The investigator estimate approximately 90 % patient GDM re-establish NGT 2-3 month post partum . This particular group patient provide unique possibility demonstrate reversibility reduce incretin effect relation optimal glycaemic control .</brief_summary>
	<brief_title>The Incretin Effect Patients With Gestational Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>age 18 year old GDM diagnose accord WHO guideline ( GDM group ) rule OGTT 75g ( Control group ) Previous diagnosis DM Positive GAD65autoantibodies and/or positive islet cell autoantibody ( ICA ) Affected biochemical liver parameter ( ALAT &gt; 2 time normal upper range ) Affected biochemical kidney parameter ( secreatinine &gt; 130 ÂµM ) Treatment medicine interact insulin secretion ( e.g . steroid ) Treatment medicine pause 16 hour</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>GDM</keyword>
	<keyword>incretin effect</keyword>
	<keyword>gestation</keyword>
	<keyword>reversibility</keyword>
</DOC>